Webcast of CEO’s presentation to Jefferies 2019 London Healthcare Conference
Melbourne (Australia) – 25th November 2019. Telix Pharmaceuticals Limited has today announced that Group CEO, Dr Christian Behrenbruch, presented at Jefferies 2019 London Healthcare Conference
Melbourne (Australia) – November 25, 2019
Telix Pharmaceuticals Limited (ASX: TLX) has today announced that Group CEO, Dr. Christian Behrenbruch, presented at Jefferies 2019 London Healthcare Conference. This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe, which hosted over 500 participating companies, 2,000 attendees and 5,000 business-to-business and investor meetings.
The Jefferies 2019 London Healthcare Conference featured leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel, Australia, China and Japan. Dr. Behrenbruch presented on Telix’s advanced clinical-stage portfolio of Molecularly Targeted Radiation (MTR) programs.
Dr. Behrenbruch’s presentation can be viewed at the Jefferies London Healthcare Conference website at http://www.wsw.com/webcast/jeff123/tlx/
To read the full media release click here.
Telix Granted FDA Breakthrough Therapy Designation for Renal Cancer Imaging Product
Melbourne (Australia) – 1st July 2020. Telix announces that the FDA has granted Breakthrough Therapy (BT) designation for Telix’s renal...
Recommencement of ZIRCON Phase III Trial Recruitment in EU
Melbourne (Australia) – 18th June 2020. Telix Pharmaceuticals Limited announces that the Company’s ZIRCON phase III trial of TLX250-CDx has...
Telix Pharmaceuticals and Pharmalogic Enter US Distribution Agreement for Prostate Cancer Imaging
Indianapolis IN and Boca Raton FL (U.S.A) – 15th May 2020. Telix Pharma (U.S.) announces it has entered into a commercial...
The Seneffe Manufacturing Site – Telix’s Next Big Move in Europe
1st May 2020 - Corporate Spotlight | Telix’s CEO Chris Behrenbruch comments on the Company’s next big move in Europe...
Seneffe Manufacturing Facility – Shareholder Walkthrough
Melbourne (Australia) 28 April 2020 - Telix Pharmaceuticals Limited provides a shareholder walkthrough of it's recently acquired Seneffe manufacturing facility
Presentation to Jefferies Virtual Healthcare Conference
Melbourne (Australia) 4th June 2020 - Telix Pharmaceuticals Limited has today announced that Group CBO Dr. David Cade presented at...